Cargando…

534 COVID-19 in people with cystic fibrosis and the general population: Severity and virus-host cell interactions

Detalles Bibliográficos
Autores principales:	Colombo, C., Alicandro, G., Bandera, A., Bouché, V., Biffi, A., Boraso, M., Cacchiarelli, D., Ciciriello, F., Cipolli, M., Gramegna, A., Itri, T., Lucidi, V., Medino, P., Rosazza, C., Galietta, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527899/ http://dx.doi.org/10.1016/S1569-1993(22)01224-3

Ejemplares similares

P054 Severity of COVID-19 infection in cystic fibrosis patients compared to the general population
por: Rosazza, C., et al.
Publicado: (2022)

Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes
por: Medino, Paola, et al.
Publicado: (2022)

P212 Clinical and transcriptomic features of COVID-19 in cystic fibrosis: a prospective multi-centre study
por: Ciciriello, F., et al.
Publicado: (2023)

Severity of SARS-CoV-2 infection in a hospital population: a clinical comparison across age groups
por: Rosazza, Chiara, et al.
Publicado: (2023)

Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis According to Disease Characteristics and Maintenance Therapies
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

Humoral and cell-mediated immune responses to BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2023)

532 Humoral and cell-mediated responses to BNT162b2 mRNA vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Daccò, V., et al.
Publicado: (2022)

ePS4.06 Antibody response to administration of 2 doses of the BNT162b2 vaccine against SARS-CoV-2 in people with cystic fibrosis
por: Alicandro, G., et al.
Publicado: (2022)

Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society
por: Colombo, Carla, et al.
Publicado: (2021)

Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells
por: Scudieri, Paolo, et al.
Publicado: (2020)

Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

SARS-CoV-2 antibodies among people with cystic fibrosis prior to the vaccination campaign: A seroprevalence study in two specialized centres in Northern Italy
por: Alicandro, Gianfranco, et al.
Publicado: (2022)

Prepuberal insulin secretory indices are long-term predictors of short adult stature in cystic fibrosis
por: Battezzati, Alberto, et al.
Publicado: (2022)

Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes
por: Grancini, V., et al.
Publicado: (2023)

P134 SARS-CoV-2 infection in cystic fibrosis during the first pandemic wave in Italy: a multi-centre prospective study with a control group
por: Colombo, C., et al.
Publicado: (2021)

ePS4.07 COVID-19 early vaccination campaign in Italian cystic fibrosis (CF) patients: the experience of the Italian Society for the Study of Cystic Fibrosis (SIFC)
por: Lucca, F., et al.
Publicado: (2022)

Distribution of OGTT-Related Variables in Patients with Cystic Fibrosis from Puberty to Adulthood: An Italian Multicenter Study
por: Foppiani, Andrea, et al.
Publicado: (2023)

An inflammatory Signature of Glucose Impairment in Cystic Fibrosis
por: Montemari, Anna Lisa, et al.
Publicado: (2022)

Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2023)

Breastfeeding in Cystic Fibrosis: A Systematic Review on Prevalence and Potential Benefits
por: Colombo, Carla, et al.
Publicado: (2021)

A successful treatment of a lobar atelectasis in a patient with cystic fibrosis
por: Daccò, Valeria, et al.
Publicado: (2022)

Is cellular senescence involved in cystic fibrosis?
por: Bezzerri, Valentino, et al.
Publicado: (2019)

SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
por: Colombo, Carla, et al.
Publicado: (2021)

Does cystic fibrosis constitute an advantage in COVID-19 infection?
por: Bezzerri, Valentino, et al.
Publicado: (2020)

WS07.06 CFTR impacts SARS-CoV-2 infection in cystic fibrosis
por: Bragonzi, A., et al.
Publicado: (2023)

Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations
por: Pedemonte, Nicoletta, et al.
Publicado: (2011)

Breast lesions in reduction mammaplasty specimens: a histopathological pattern in 534 patients
por: Tadler, M, et al.
Publicado: (2014)

Assessing the landscape of STXBP1-related disorders in 534 individuals
por: Xian, Julie, et al.
Publicado: (2021)

534. Active Screening for Carbapenemase Producing Enterobacteriaceae: Yield and Cost Considerations
por: Ramos-Castaneda, Jorge A, et al.
Publicado: (2019)

Exam ref 70-534 architecting Microsoft Azure solutions
por: Bai, Haishi, et al.
Publicado: (2015)

Correction to Lancet Haematol 2020; 7: e534–40
Publicado: (2020)

Attitudes and perspectives of 534 Chinese pediatricians toward internet hospitals
por: Cui, Wenbin, et al.
Publicado: (2022)

509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis
por: Bezzerri, V., et al.
Publicado: (2022)

State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium
por: Ciet, Pierluigi, et al.
Publicado: (2022)

Night Blindness in Cystic Fibrosis: The Key Role of Vitamin A in the Digestive System
por: Norsa, Lorenzo, et al.
Publicado: (2019)

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
por: Taccetti, Giovanni, et al.
Publicado: (2021)

Easy-to-Build and Reusable Microfluidic Device for the Dynamic Culture of Human Bronchial Cystic Fibrosis Epithelia
por: Mazio, Claudia, et al.
Publicado: (2023)

Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patients
por: Driedger, Michael R., et al.
Publicado: (2020)

299: Stress and mental health in cystic fibrosis 1 year after the COVID pandemic: Findings from an Italian sample
por: Graziano, S., et al.
Publicado: (2021)

534 Clinical Characteristics of Eosinophilic Asthma Compared to Noneosinophilic Asthma in Children
por: Lee, Yong Ju, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l58p1trovnf8lf5pir8unalv0a